Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium in COPD with concomitant asthma
2004-002166-38Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and asthma comparing Tiotropium 18 micrograms once daily with Placebo once daily (2 arms). Primary endpoint: Forced expiratory volume in 1 second. Started Nov 2004; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on 2004-002166-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002166-38.